Cargando…

Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?

Multiple myeloma (MM) is a plasma cell malignancy that affects an increasing number of patients worldwide. Despite all the efforts to understand its pathogenesis and develop new treatment modalities, MM remains an incurable disease. Novel immunotherapies, such as CAR T cell therapy (CAR) and bispeci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kegyes, David, Constantinescu, Catalin, Vrancken, Louise, Rasche, Leo, Gregoire, Celine, Tigu, Bogdan, Gulei, Diana, Dima, Delia, Tanase, Alina, Einsele, Hermann, Ciurea, Stefan, Tomuleasa, Ciprian, Caers, Jo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171942/ https://www.ncbi.nlm.nih.gov/pubmed/35672793 http://dx.doi.org/10.1186/s13045-022-01296-2

Ejemplares similares

Outcomes of CAR-T Cell Therapy Recipients Admitted to the ICU: In Search for a Standard of Care—A Brief Overview and Meta-Analysis of Proportions
por: Constantinescu, Catalin, et al.
Publicado: (2023)

Design and preclinical testing of an anti‐CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia
por: Tigu, Adrian Bogdan, et al.
Publicado: (2023)

Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia
por: Deak, Dalma, et al.
Publicado: (2019)

Clinical Approach to the Patient in Critical State Following Immunotherapy and/or Stem Cell Transplantation: Guideline for the On-Call Physician
por: Constantinescu, Catalin, et al.
Publicado: (2019)

RNA sequencing suggests that non‐coding RNAs play a role in the development of acquired haemophilia
por: Tigu, Adrian Bogdan, et al.
Publicado: (2023)

Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
por: Constantinescu, Catalin, et al.
Publicado: (2020)

Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy
por: Iluta, Sabina, et al.
Publicado: (2021)

Mechanistic Insights in Hemophagocytic Lymphohistiocytosis: Subsequent Acute Hepatic Failure in a Multiple Myeloma Patient Following Therapy with Ixazomib-Lenalidomide-Dexamethasone
por: Constantinescu, Catalin, et al.
Publicado: (2022)

The Predictive Role of Modified Early Warning Score in 174 Hematological Patients at the Point of Transfer to the Intensive Care Unit
por: Constantinescu, Catalin, et al.
Publicado: (2021)

CAR-T cells and BiTEs in solid tumors: challenges and perspectives
por: Edeline, Julien, et al.
Publicado: (2021)

Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
por: Constantinescu, Catalin, et al.
Publicado: (2020)

COVID-19 Impact on Chronic Myeloid Leukemia Patients
por: Arbore, Dana Raluca, et al.
Publicado: (2022)

Optimization of Tyrosine Kinase Inhibitor-Loaded Gold Nanoparticles for Stimuli-Triggered Antileukemic Drug Release
por: Tatar, Andra-Sorina, et al.
Publicado: (2023)

B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?
por: Desmirean, Minodora, et al.
Publicado: (2020)

The Possible Non-Mutational Causes of FVIII Deficiency: Non-Coding RNAs and Acquired Hemophilia A
por: Zimta, Alina-Andreea, et al.
Publicado: (2021)

The Effect of Different Anesthetic Techniques on Proliferation, Apoptosis, and Gene Expression in Colon Cancer Cells: A Pilot In Vitro Study
por: Alexa, Alexandru Leonard, et al.
Publicado: (2023)

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
por: Pasca, Sergiu, et al.
Publicado: (2019)

Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and Beyond
por: Epperly, Rebecca, et al.
Publicado: (2020)

Targeting the Microenvironment in MDS: The Final Frontier
por: Teodorescu, Patric, et al.
Publicado: (2020)

The Malignant Role of Exosomes as Nanocarriers of Rare RNA Species
por: Zimta, Alina-Andreea, et al.
Publicado: (2020)

BiTE‐Secreting CAR‐γδT as a Dual Targeting Strategy for the Treatment of Solid Tumors
por: Huang, Shi‐Wei, et al.
Publicado: (2023)

Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies
por: Cenariu, Diana, et al.
Publicado: (2022)

Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective
por: Munteanu, Raluca, et al.
Publicado: (2023)

Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma
por: Li, Gaowei, et al.
Publicado: (2021)

Low-Molecular-Weight Heparins (LMWH) and Synthetic Factor X Inhibitors Can Impair the Osseointegration Process of a Titanium Implant in an Interventional Animal Study
por: Apostu, Dragos, et al.
Publicado: (2022)

Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies
por: Gulei, Diana, et al.
Publicado: (2020)

Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO)
por: Colita, Andrei, et al.
Publicado: (2023)

A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)
por: Stone, Jennifer D., et al.
Publicado: (2012)

The Influence of Methylating Mutations on Acute Myeloid Leukemia: Preliminary Analysis on 56 Patients
por: Pasca, Sergiu, et al.
Publicado: (2020)

Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
por: Tomuleasa, Ciprian, et al.
Publicado: (2018)

Transforming growth factor β‐mediated micromechanics modulates disease progression in primary myelofibrosis
por: Teodorescu, Patric, et al.
Publicado: (2020)

Genetically enhanced T lymphocytes and the intensive care unit
por: Tat, Tiberiu, et al.
Publicado: (2018)

Correction: Genetically enhanced T lymphocytes and the intensive care unit
por: Tat, Tiberiu, et al.
Publicado: (2018)

Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies
por: Kojima, Seiji, et al.
Publicado: (2014)

Advances in the treatment of newly diagnosed primary central nervous system lymphomas
por: Qian, Liren, et al.
Publicado: (2017)

Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation
por: Zaharie, Florin, et al.
Publicado: (2015)

Bicytopenia as a paraneoplastic syndrome for pseudomyxoma peritonei. Hematologic manifestations of a subtle disease
por: Tomuleasa, Ciprian, et al.
Publicado: (2015)

The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia
por: Jimbu, Laura, et al.
Publicado: (2021)

The Potential of Different Origin Stem Cells in Modulating Oral Bone Regeneration Processes
por: Buduru, Smaranda Dana, et al.
Publicado: (2019)

Novel Immune Engagers and Cellular Therapies for Metastatic Castration-Resistant Prostate Cancer: Do we take a BiTe or ride BiKEs, TriKEs, and CARs?
por: Zorko, Nicholas A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b28cnf9pbtjqg2jjnffg6te28m